SOPHiA GENETICS SA (SOPH) CEO Dr. Jurgi Camblong on Q2 2022

SOPHiA GENETICS SA (NASDAQ:NASDAQ:SOPH) Q2 2022 Results Conference Call August 09, 2022 08:30 AM ET Company Participants Jennifer Pottage - Head, IR Dr.

Related Keywords

New York , United States , Switzerland , Turkey , Turkish , America , Swiss , Vidyun Bais , Julia Qin , Kyle Boucher , Mark Massaro , Jurgi Camblong , Ross Muken , Dan Brennan , Philip Mooney , Company Participants , Morgan Stanley , Astrazeneca , Jp Morgan , Ge Healthcare , Conference Call August , Fiscal Quarter , Jennifer Pottage , Second Fiscal , Investor Relations , Chief Executive Officer , Chief Financial , North America , Chief Medical Officer , Investor Day , Tejas Savant , Analyst Day ,